Hercules Capital, Inc. (HTGC): Price and Financial Metrics

Hercules Capital, Inc. (HTGC): $17.17

0.08 (+0.47%)

POWR Rating

Component Grades

Momentum

B

Stability

C

Sentiment

Quality

C

Add HTGC to Watchlist
Sign Up

Industry: Private Equity

Industry

D

Ranked

#20 of 34

in industry

HTGC Price/Volume Stats

Current price $17.17 52-week high $18.05
Prev. close $17.09 52-week low $10.94
Day low $16.99 Volume 471,200
Day high $17.20 Avg. volume 746,589
50-day MA $16.61 Dividend yield 9.29%
200-day MA $15.76 Market Cap 2.60B

HTGC Stock Price Chart Interactive Chart >

HTGC POWR Grades

  • Momentum is the dimension where HTGC ranks best; there it ranks ahead of 74.09% of US stocks.
  • HTGC's strongest trending metric is Growth; it's been moving down over the last 26 weeks.
  • HTGC ranks lowest in Growth; there it ranks in the 14th percentile.

HTGC Stock Summary

  • The ratio of debt to operating expenses for HERCULES CAPITAL INC is higher than it is for about 96.47% of US stocks.
  • Over the past twelve months, HTGC has reported earnings growth of 249.97%, putting it ahead of 95.36% of US stocks in our set.
  • As for revenue growth, note that HTGC's revenue has grown 49.08% over the past 12 months; that beats the revenue growth of 90.79% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to HERCULES CAPITAL INC, a group of peers worth examining would be VGR, RYAM, TRIN, CSV, and WSR.
  • Visit HTGC's SEC page to see the company's official filings. To visit the company's web site, go to www.htgc.com.

HTGC Valuation Summary

  • In comparison to the median Financial Services stock, HTGC's EV/EBIT ratio is 2.93% lower, now standing at 11.6.
  • HTGC's price/earnings ratio has moved up 911.8 over the prior 225 months.

Below are key valuation metrics over time for HTGC.

Stock Date P/S P/B P/E EV/EBIT
HTGC 2023-12-22 5.7 1.5 8.9 11.6
HTGC 2023-12-21 5.6 1.5 8.8 11.5
HTGC 2023-12-20 5.6 1.5 8.7 11.5
HTGC 2023-12-19 5.6 1.5 8.8 11.5
HTGC 2023-12-18 5.5 1.5 8.7 11.4
HTGC 2023-12-15 5.5 1.4 8.5 11.3

HTGC Growth Metrics

    Its year over year price growth rate is now at -3.71%.
  • The 5 year revenue growth rate now stands at 54.92%.
  • Its 2 year net income to common stockholders growth rate is now at 28.05%.
HTGC's revenue has moved up $37,845,000 over the prior 15 months.

The table below shows HTGC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 321.688 -424.799 102.081
2022-09-30 293.966 -259.941 43.26
2022-06-30 279.93 -165.901 13.607
2022-03-31 277.374 -9.582 106.656
2021-12-31 280.976 128.621 174.155
2021-09-30 283.843 260.498 321.615

HTGC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • HTGC has a Quality Grade of B, ranking ahead of 78.29% of graded US stocks.
  • HTGC's asset turnover comes in at 0.107 -- ranking 195th of 444 Trading stocks.
  • BX, AIV, and WY are the stocks whose asset turnover ratios are most correlated with HTGC.

The table below shows HTGC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.107 1 0.102
2021-06-30 0.110 1 0.109
2021-03-31 0.111 1 0.104
2020-12-31 0.115 1 0.079
2020-09-30 0.115 1 0.050
2020-06-30 0.117 1 0.044

Hercules Capital, Inc. (HTGC) Company Bio


Hercules Technology Growth Capital, Inc. is a business development company specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and re-financings and established-stage companies. The company was founded in 2003 and is based in Palo Alto, California.


HTGC Latest News Stream


Event/Time News Detail
Loading, please wait...

HTGC Latest Social Stream


Loading social stream, please wait...

View Full HTGC Social Stream

Latest HTGC News From Around the Web

Below are the latest news stories about HERCULES CAPITAL INC that investors may wish to consider to help them evaluate HTGC as an investment opportunity.

Hercules Capital (HTGC) Outperforms Broader Market: What You Need to Know

In the latest trading session, Hercules Capital (HTGC) closed at $16.41, marking a +0.98% move from the previous day.

Yahoo | December 22, 2023

enGene Announces Expanded $50 Million Debt Facility with Hercules Capital

enGene Holdings Inc. ("enGene," Nasdaq: ENGN), a clinical-stage genetic medicines company whose lead EG-70 program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), announced today that it has entered into an amended USD $50 million loan agreement (the "Loan Agreement") with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). Under the Loan Agreement, which has a term of four years, $22.5 million has been advanced to enGene under a non-revolving term loan and,

Yahoo | December 22, 2023

Investors in Hercules Capital (NYSE:HTGC) have seen splendid returns of 155% over the past five years

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...

Yahoo | December 17, 2023

This Dividend Stock Has Returned 157% Over the Past 10 Years. You Can Buy It Today for Just $15

Hercules Technology Growth Capital makes high-yield loans to energy, life sciences, and technology businesses.

Yahoo | December 15, 2023

Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital

Amendment provides more favorable terms including a 14-month extension of the interest-only period and maturity date until December 2027Up to an additional $100 million in non-dilutive capital available subject to the achievement of certain revenue milestonesCash runway now expected through the end of 2026 FLORHAM PARK, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for g

Yahoo | December 14, 2023

Read More 'HTGC' Stories Here

HTGC Price Returns

1-mo -1.32%
3-mo 10.42%
6-mo 6.20%
1-year 34.48%
3-year 54.64%
5-year 128.82%
YTD 3.00%
2023 42.91%
2022 -9.51%
2021 25.99%
2020 15.13%
2019 39.86%

HTGC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full HTGC Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!